维普中文期刊产品整合服务
13篇 您的检索式:作者名="Cheinquer H"
    题名 作者 年代 出处 被引量
1Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study 显示文摘Liaw Y F Raptopoulou-Gigi M Cheinquer H 2011Hepatology2011,54,1:1
2Viral pathogenesis of hepatocellular carcinoma in the United States显示文摘Liang TJ Jeffers L J Reddy KR De Medina M Parker IT Cheinquer H Hepatology0,,:1
3High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials 显示文摘MARCELLIN P CHEINQUER H CURESCU M 2012Hepatology2012,56,6:1
4Prevalence of hep- atitis C virus infection in patients with COPD 显示文摘Silva DR Stifft J Cheinquer H 2010Epi- demiol Infect2010,138,2:1
5Procollagen-III peptide and chronic viral C Hepatitis显示文摘Jeffers LJ Coelho-little ME Cheinquer H 1995Am J Gastroentereol1995,90,9:1
6Entecavir versus lamivudine orpalients with HBeAg negative chronic hepatitis B显示文摘Lai C L Shouval D Lok A S Chang T T Cheinquer H Good man Z el al 2006N Engl J Med2006,354,:1
7Procollagen Ⅲ peptide and chronic viral hepatitis显示文摘Jeffers L J Coelho-Little M E Cheinquer H 1995Am J Gastroenterol1995,90,9:1
8Effect of sustained virologic response on the incidence of hepa- tocellular carcinoma in patients with HCV cirrhosis 显示文摘Cheinquer N Cheinquer H Wolff FH 2010Braz J Infect Dis2010,14,5:1
9High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials 显示文摘Marcellin P Cheinquer H Curescu M 2012Hepatology2012,56,6:1
10Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study显示文摘Liaw YF Raptopoulou-Gigi M Cheinquer H 2011Hepatology2011,54,1:1
11Peginterferon alfa-2a ( 40kD ) ( PEGASYS ) in combination with ribavirin (RBV) :efficacy and safety results from a phase Ⅲ, randomized, double-blind multicentre study examining effect of duration of treatment and RBV dose 显示文摘 Cheinquer H Morgan T 2002J Hepatol2002,36,1:1
12Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study显示文摘Liaw YF Raptopoulou-Gigi M Cheinquer H 2011Hepatology2011,54,:1
13Peginterferon alfa-2a (40 kD) (Pegasys) in combination with ribavirin (RBV): efficacy and safety results from a phase Ⅲ, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose显示文摘Hadziyannis SJ Cheinquer H Morgan T 2002J Hepatol2002,36,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费